Optio RX Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 260

Employees

  • Latest Deal Type
  • Debt

  • Financing Rounds
  • 8

  • Investments
  • 6

Optio RX General Information

Description

Operator of specialty compounding pharmacies and home infusion providers licensed across the United States. The company engages in partnership with specialty pharmacies to provide patient care in a broad range of therapeutic classes, including fertility, hormone replacement therapy, veterinary and home infusion therapy, thereby enabling partners to meet their financial and personal objectives.

Contact Information

Website
www.optiorx.com
Ownership Status
Privately Held (backing)
Financing Status
Formerly PE-Backed
Corporate Office
  • 11770 US Highway One
  • Suite 402
  • Palm Beach Gardens, FL 33408
  • United States
+1 (630)
Primary Industry
Other Healthcare Services
Other Industries
Specialty Retail
Corporate Office
  • 11770 US Highway One
  • Suite 402
  • Palm Beach Gardens, FL 33408
  • United States
+1 (630)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Optio RX Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Optio RX‘s full profile, request access.

Request a free trial

Optio RX Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Optio RX Investments (6)

Optio RX’s most recent deal was a Buyout/LBO with Dr. Ike's Pharmacare. The deal was made on 01-Jun-2019.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Dr. Ike's Pharmacare 01-Jun-2019 Buyout/LBO Other Healthcare Services
H & H Pharmacy 01-Jun-2019 Buyout/LBO Specialty Retail
Crestview Holdings 01-Dec-2018 Buyout/LBO Other Financial Services
The Pet Apothecary 01-Oct-2018 Buyout/LBO Other Services (B2C Non-Financial)
HemaCare Plus 01-Jul-2018 Buyout/LBO Education and Training Services (B2B)
You’re viewing 5 of 6 investments. Get the full list »

Optio RX Exits (1)

Optio RX’s most recent exit was on 01-Oct-2018 from The Pet Apothecary. The exit was categorized as with 4 buyers.

Company Name Exit Date Exit Type Exit Size Status Buyers
The Pet Apothecary 01-Oct-2018 Completed
  • 4 buyers
To view Optio RX’s complete exits history, request access »

Optio RX Affiliates

Subsidiaries (5)

Name Industry Location Year Founded
Dr. Ike's Pharmacare Sylmar, CA 2010
Lyons Smc Holdings Chicago, IL 2000
Braun PharmaCare Chicago, IL 1987
H & H Pharmacy Chincoteague Island, VA 1929
HemaCare Plus Spanish Fort, AL

Optio RX FAQs

  • When was Optio RX founded?

    Optio RX was founded in 2018.

  • Where is Optio RX headquartered?

    Optio RX is headquartered in Palm Beach Gardens, FL.

  • What is the size of Optio RX?

    Optio RX has 260 total employees.

  • What industry is Optio RX in?

    Optio RX’s primary industry is Other Healthcare Services.

  • Is Optio RX a private or public company?

    Optio RX is a Private company.

  • What is Optio RX’s current revenue?

    The current revenue for Optio RX is .

  • How much funding has Optio RX raised over time?

    Optio RX has raised $25.1M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process